Overview

Pharmacokinetics and Safety of Ticarcillin-clavulanate in Infants

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety, tolerability and PK of ticarcillin-clavulanate in infants <91 days of age with suspected systemic infection.
Phase:
Phase 1
Details
Lead Sponsor:
Phillip Brian Smith
Treatments:
Clavulanic Acid
Clavulanic Acids
Ticarcillin
Ticarcillin-clavulanic acid